Suzhou Highfine Biotech Co., Ltd. (SHE:301393)
China · Delayed Price · Currency is CNY 62.40
-0.87 (-1.38%)
At close: Oct 9, 2026
Suzhou Highfine Biotech Revenue
Suzhou Highfine Biotech had revenue of 207.29M CNY in the quarter ending June 30, 2026, with 53.45% growth. This brings the company's revenue in the last twelve months to 711.19M, up 43.06% year-over-year. In the year 2025, Suzhou Highfine Biotech had annual revenue of 602.26M with 33.28% growth. That makes Suzhou Highfine Biotech the 22,160th largest company in the world by revenue and 4,043rd in China.
Revenue (ttm)
711.19M
Revenue Growth
+43.06%
P/S Ratio
9.40
Revenue / Employee
1.05M
Employees
678
Market Cap
6.69B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 602.26M | 150.39M | 33.28% |
| Dec 31, 2024 | 451.87M | 63.08M | 16.22% |
| Dec 31, 2023 | 388.79M | -58.66M | -13.11% |
| Jan 1, 2023 | 447.46M | 78.02M | 21.12% |
| Dec 31, 2021 | 369.44M | 87.09M | 30.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.